Your browser doesn't support javascript.
loading
Proceedings of the Seventh Annual Deep Brain Stimulation Think Tank: Advances in Neurophysiology, Adaptive DBS, Virtual Reality, Neuroethics and Technology.
Ramirez-Zamora, Adolfo; Giordano, James; Gunduz, Aysegul; Alcantara, Jose; Cagle, Jackson N; Cernera, Stephanie; Difuntorum, Parker; Eisinger, Robert S; Gomez, Julieth; Long, Sarah; Parks, Brandon; Wong, Joshua K; Chiu, Shannon; Patel, Bhavana; Grill, Warren M; Walker, Harrison C; Little, Simon J; Gilron, Ro'ee; Tinkhauser, Gerd; Thevathasan, Wesley; Sinclair, Nicholas C; Lozano, Andres M; Foltynie, Thomas; Fasano, Alfonso; Sheth, Sameer A; Scangos, Katherine; Sanger, Terence D; Miller, Jonathan; Brumback, Audrey C; Rajasethupathy, Priya; McIntyre, Cameron; Schlachter, Leslie; Suthana, Nanthia; Kubu, Cynthia; Sankary, Lauren R; Herrera-Ferrá, Karen; Goetz, Steven; Cheeran, Binith; Steinke, G Karl; Hess, Christopher; Almeida, Leonardo; Deeb, Wissam; Foote, Kelly D; Okun, Michael S.
Afiliación
  • Ramirez-Zamora A; Department of Neurology, Norman Fixel Institute for Neurological Diseases, Program for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Giordano J; Departments of Neurology and Biochemistry, and Neuroethics Studies Program-Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, United States.
  • Gunduz A; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Alcantara J; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Cagle JN; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Cernera S; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Difuntorum P; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Eisinger RS; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Gomez J; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Long S; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Parks B; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Wong JK; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Chiu S; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Patel B; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Grill WM; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Walker HC; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Little SJ; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Gilron R; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Tinkhauser G; J. Crayton Pruitt Family Department of Biomedical Engineering, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Thevathasan W; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Sinclair NC; Department of Neurology, Norman Fixel Institute for Neurological Diseases, Program for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Lozano AM; Department of Neurology, Norman Fixel Institute for Neurological Diseases, Program for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Foltynie T; Department of Neurology, Norman Fixel Institute for Neurological Diseases, Program for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, United States.
  • Fasano A; Department of Biomedical Engineering, Duke University, Durham, NC, United States.
  • Sheth SA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Scangos K; Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Sanger TD; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
  • Miller J; Graduate Program in Neuroscience, Department of Neurological Surgery, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, United States.
  • Brumback AC; Department of Neurology, Bern University Hospital and the University of Bern, Bern, Switzerland.
  • Rajasethupathy P; Medical Research Council Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom.
  • McIntyre C; Department of Neurology, The Royal Melbourne and Austin Hospitals, University of Melbourne, Melbourne, VIC, Australia.
  • Schlachter L; Medical Bionics Department, University of Melbourne, East Melbourne, VIC, Australia.
  • Suthana N; Bionics Institute, East Melbourne, VIC, Australia.
  • Kubu C; Medical Bionics Department, University of Melbourne, East Melbourne, VIC, Australia.
  • Sankary LR; Bionics Institute, East Melbourne, VIC, Australia.
  • Herrera-Ferrá K; Department of Surgery, Division of Neurosurgery, University of Toronto, Toronto, ON, Canada.
  • Goetz S; Institute of Neurology, University College London, London, United Kingdom.
  • Cheeran B; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
  • Steinke GK; Division of Neurology, University of Toronto, Krembil Brain Institute, Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada.
  • Hess C; Department of Neurological Surgery, Baylor College of Medicine, Houston, TX, United States.
  • Almeida L; Department of Psychiatry, University of California, San Francisco, San Francisco, CA, United States.
  • Deeb W; Department of Biomedical Engineering, Neurology, Biokinesiology, University of Southern California, Los Angeles, CA, United States.
  • Foote KD; Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
  • Okun MS; Departments of Neurology and Pediatrics at Dell Medical School and the Center for Learning and Memory, University of Texas at Austin, Austin, TX, United States.
Front Hum Neurosci ; 14: 54, 2020.
Article en En | MEDLINE | ID: mdl-32292333
ABSTRACT
The Seventh Annual Deep Brain Stimulation (DBS) Think Tank held on September 8th of 2019 addressed the most current (1) use and utility of complex neurophysiological signals for development of adaptive neurostimulation to improve clinical outcomes; (2) Advancements in recent neuromodulation techniques to treat neuropsychiatric disorders; (3) New developments in optogenetics and DBS; (4) The use of augmented Virtual reality (VR) and neuromodulation; (5) commercially available technologies; and (6) ethical issues arising in and from research and use of DBS. These advances serve as both "markers of progress" and challenges and opportunities for ongoing address, engagement, and deliberation as we move to improve the functional capabilities and translational value of DBS. It is in this light that these proceedings are presented to inform the field and initiate ongoing discourse. As consistent with the intent, and spirit of this, and prior DBS Think Tanks, the overarching goal is to continue to develop multidisciplinary collaborations to rapidly advance the field and ultimately improve patient outcomes.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Hum Neurosci Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Hum Neurosci Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos